Tybourne Capital Management (Hk) LTD Portfolio Holdings
Tybourne Capital Management (Hk) LTD
- $23.6 Billion
- Q1 2025
Tybourne Capital Management (Hk) LTD has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $23.6 Billion distributed in 5 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Acelyrin Inc (Slrn Us) with a value of $7.18B, Taysha Gene Therapies, Inc. with a value of $5.14B, Bicycle Therapeutics PLC with a value of $4.89B, Forte Biosciences Inc (Fbrx Us) with a value of $4.81B, and Zentalis Pharmaceuticals, Inc. with a value of $1.53B.
Examining the 13F form we can see an increase of $23.2B in the current position value, from $315M to 23.6B.
Tybourne Capital Management (Hk) LTD is based out at Hong Kong, K3
Below you can find more details about Tybourne Capital Management (Hk) LTD portfolio as well as his latest detailed transactions.